These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21993655)

  • 1. Analysis of the immune response to Neisseria meningitidis using a proteomics approach.
    Williams JN; Christodoulides M; Heckels JE
    Methods Mol Biol; 2012; 799():343-60. PubMed ID: 21993655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
    Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
    Bisaillon JG; McSween G; Portelance V; Beaudet R; Morosoli R; Pouliot P; Micusan V
    Microbios; 1989; 60(244-245):193-208. PubMed ID: 2515422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential.
    Hsu CA; Lin WR; Li JC; Liu YL; Tseng YT; Chang CM; Lee YS; Yang CY
    Proteomics; 2008 May; 8(10):2115-25. PubMed ID: 18491322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.
    Bai X; Borrow R
    Expert Rev Vaccines; 2010 Oct; 9(10):1203-17. PubMed ID: 20923270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inventory of the proteins in Neisseria meningitidis serogroup B strain MC58.
    Mignogna G; Giorgi A; Stefanelli P; Neri A; Colotti G; Maras B; Schininà ME
    J Proteome Res; 2005; 4(4):1361-70. PubMed ID: 16083288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal vaccines.
    Bethell D; Pollard AJ
    Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.
    Vaughan TE; Skipp PJ; O'Connor CD; Hudson MJ; Vipond R; Elmore MJ; Gorringe AR
    Vaccine; 2006 Jun; 24(25):5277-93. PubMed ID: 16682101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Moraxella catarrhalis outer membrane antigens cross-reactive with Neisseria meningitidis and Neisseria lactamica.
    Troncoso G; Sánchez S; Criado MT; Ferreirós C
    FEMS Immunol Med Microbiol; 2004 Jan; 40(1):89-94. PubMed ID: 14734192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postgenomics of Neisseria meningitidis for vaccines development.
    Bernardini G; Braconi D; Martelli P; Santucci A
    Expert Rev Proteomics; 2007 Oct; 4(5):667-77. PubMed ID: 17941821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry.
    Uli L; Castellanos-Serra L; Betancourt L; Domínguez F; Barberá R; Sotolongo F; Guillén G; Pajón Feyt R
    Proteomics; 2006 Jun; 6(11):3389-99. PubMed ID: 16673438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoproteomic identification of polyvalent vaccine candidates from Vibrio parahaemolyticus outer membrane proteins.
    Li H; Ye MZ; Peng B; Wu HK; Xu CX; Xiong XP; Wang C; Wang SY; Peng XX
    J Proteome Res; 2010 May; 9(5):2573-83. PubMed ID: 20148598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of broad cross-protective immunogens using heterogeneous antiserum-based immunoproteomic approach.
    Li H; Xiong XP; Peng B; Xu CX; Ye MZ; Yang TC; Wang SY; Peng XX
    J Proteome Res; 2009 Sep; 8(9):4342-9. PubMed ID: 19640004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254.
    Vipond C; Suker J; Jones C; Tang C; Feavers IM; Wheeler JX
    Proteomics; 2006 Jun; 6(11):3400-13. PubMed ID: 16645985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal Neisseria species.
    Troncoso G; Sánchez S; Moreda M; Criado MT; Ferreirós CM
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):103-9. PubMed ID: 10640604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
    Heyderman RS; Davenport V; Williams NA
    Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of vaccine candidates from differentially expressed outer membrane proteins of Vibrio alginolyticus in response to NaCl and iron limitation.
    Xiong XP; Zhang BW; Yang MJ; Ye MZ; Peng XX; Li H
    Fish Shellfish Immunol; 2010 Nov; 29(5):810-6. PubMed ID: 20659563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 20. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
    Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
    Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.